{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Endoscopic+marker&page=2", "query": { "intervention": "Endoscopic marker", "page": 2 }, "page_size": 10 }, "pagination": { "page": 2, "page_size": 10, "total_count": 10, "total_pages": 1, "next_page_url": null, "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Endoscopic+marker&page=1&page_size=10" }, "source": "remote", "last_synced_at": "2026-09-23T19:36:25.167Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT01469546", "title": "Phase II Trial Evaluating Axitinib In Patients With Unresectable, Recurrent Or Metastatic Head And Neck Cancer", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Head and Neck Squamous Cell Carcinoma" ], "interventions": [ { "name": "Axitinib (AG-013736)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University of Michigan Rogel Cancer Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 42, "start_date": "2012-01", "completion_date": "2016-03", "has_results": true, "last_update_posted_date": "2016-08-29", "last_synced_at": "2026-09-23T19:36:25.167Z", "location_count": 1, "location_summary": "Ann Arbor, Michigan", "locations": [ { "city": "Ann Arbor", "state": "Michigan" } ], "official_url": "https://clinicaltrials.gov/study/NCT01469546" }, { "nct_id": "NCT02531113", "title": "Efficacy and Safety Trial of RPC1063 for Moderate to Severe Crohn's Disease", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Crohn's Disease" ], "interventions": [ { "name": "RPC1063", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Celgene", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 69, "start_date": "2015-10-09", "completion_date": "2019-11-28", "has_results": true, "last_update_posted_date": "2021-01-22", "last_synced_at": "2026-09-23T19:36:25.167Z", "location_count": 13, "location_summary": "Tucson, Arizona • Largo, Florida • Palmetto Bay, Florida + 10 more", "locations": [ { "city": "Tucson", "state": "Arizona" }, { "city": "Largo", "state": "Florida" }, { "city": "Palmetto Bay", "state": "Florida" }, { "city": "Suwanee", "state": "Georgia" }, { "city": "Oak Lawn", "state": "Illinois" } ], "official_url": "https://clinicaltrials.gov/study/NCT02531113" }, { "nct_id": "NCT02246647", "title": "Biomarkers for Intestinal Permeability in Patients With Constipation", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Intestinal Diseases", "Irritable Bowel Syndrome", "Constipation" ], "interventions": [ { "name": "Permeability measurement", "type": "DIAGNOSTIC_TEST" }, { "name": "Esophagogastroduodenoscopy", "type": "PROCEDURE" }, { "name": "Flexible sigmoidoscopy", "type": "PROCEDURE" } ], "intervention_types": [ "DIAGNOSTIC_TEST", "PROCEDURE" ], "sponsor": "Mayo Clinic", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "FEMALE", "summary": "18 Years to 65 Years · Female only" }, "enrollment_count": 39, "start_date": "2014-09", "completion_date": "2016-12-08", "has_results": true, "last_update_posted_date": "2019-08-21", "last_synced_at": "2026-09-23T19:36:25.167Z", "location_count": 1, "location_summary": "Rochester, Minnesota", "locations": [ { "city": "Rochester", "state": "Minnesota" } ], "official_url": "https://clinicaltrials.gov/study/NCT02246647" }, { "nct_id": "NCT02100189", "title": "Esophageal Cytology With FISH in Detecting Esophageal Cancer", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Dysphagia", "Dysplasia", "Esophageal Adenocarcinoma", "Esophageal Squamous Cell Carcinoma", "Esophagitis", "Gastroesophageal Reflux Disease", "High Grade Dysplasia in Barrett Esophagus", "Weight Loss" ], "interventions": [ { "name": "Cytology Specimen Collection Procedure", "type": "OTHER" }, { "name": "Esophagogastroduodenoscopy", "type": "PROCEDURE" }, { "name": "Laboratory Biomarker Analysis", "type": "OTHER" } ], "intervention_types": [ "OTHER", "PROCEDURE" ], "sponsor": "OHSU Knight Cancer Institute", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 50, "start_date": "2014-02", "completion_date": "2015-12", "has_results": true, "last_update_posted_date": "2017-05-11", "last_synced_at": "2026-09-23T19:36:25.167Z", "location_count": 1, "location_summary": "Portland, Oregon", "locations": [ { "city": "Portland", "state": "Oregon" } ], "official_url": "https://clinicaltrials.gov/study/NCT02100189" }, { "nct_id": "NCT04239573", "title": "Comparing the Clinical Impact of Pancreatic Cyst Surveillance Programs and Associated Biomarkers", "overall_status": "RECRUITING", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Pancreatic Neoplasm" ], "interventions": [ { "name": "Biopsy Procedure", "type": "PROCEDURE" }, { "name": "Biospecimen Collection", "type": "PROCEDURE" }, { "name": "Computed Tomography", "type": "PROCEDURE" }, { "name": "Endoscopic Ultrasound", "type": "PROCEDURE" }, { "name": "Endoscopic Ultrasound-Guided Fine-Needle Aspiration", "type": "PROCEDURE" }, { "name": "Magnetic Resonance Imaging", "type": "PROCEDURE" }, { "name": "Quality-of-Life Assessment", "type": "OTHER" }, { "name": "Questionnaire Administration", "type": "OTHER" }, { "name": "Surgical Procedure", "type": "PROCEDURE" } ], "intervention_types": [ "PROCEDURE", "OTHER" ], "sponsor": "ECOG-ACRIN Cancer Research Group", "sponsor_class": "NETWORK", "healthy_volunteers": false, "eligibility": { "minimum_age": "50 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "50 Years to 75 Years" }, "enrollment_count": 770, "start_date": "2020-06-16", "completion_date": "2034-11-11", "has_results": false, "last_update_posted_date": "2026-09-04", "last_synced_at": "2026-09-23T19:36:25.167Z", "location_count": 413, "location_summary": "Birmingham, Alabama • Mobile, Alabama • Anchorage, Alaska + 294 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Mobile", "state": "Alabama" }, { "city": "Anchorage", "state": "Alaska" }, { "city": "Anchorage", "state": "Alaska" }, { "city": "Anchorage", "state": "Alaska" } ], "official_url": "https://clinicaltrials.gov/study/NCT04239573" }, { "nct_id": "NCT00095589", "title": "Microsatellite Analysis of Urinary Sediment in Detecting Bladder Cancer", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Bladder Cancer" ], "interventions": [ { "name": "loss of heterozygosity analysis", "type": "GENETIC" }, { "name": "microarray analysis", "type": "GENETIC" }, { "name": "microsatellite instability analysis", "type": "GENETIC" }, { "name": "cytology specimen collection procedure", "type": "OTHER" }, { "name": "laboratory biomarker analysis", "type": "OTHER" }, { "name": "computed tomography", "type": "PROCEDURE" }, { "name": "cystoscopy", "type": "PROCEDURE" } ], "intervention_types": [ "GENETIC", "OTHER", "PROCEDURE" ], "sponsor": "Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "40 Years", "maximum_age": "120 Years", "sex": "ALL", "summary": "40 Years to 120 Years" }, "enrollment_count": 125, "start_date": "2004-08", "completion_date": "2009-06", "has_results": false, "last_update_posted_date": "2019-02-08", "last_synced_at": "2026-09-23T19:36:25.167Z", "location_count": 12, "location_summary": "Birmingham, Alabama • Stanford, California • Chicago, Illinois + 8 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Stanford", "state": "California" }, { "city": "Chicago", "state": "Illinois" }, { "city": "Baltimore", "state": "Maryland" }, { "city": "Ann Arbor", "state": "Michigan" } ], "official_url": "https://clinicaltrials.gov/study/NCT00095589" }, { "nct_id": "NCT00001693", "title": "Phase I-II Multiple-Dose Safety and Efficacy Study of a Selective Inhibitor of Cyclooxygenase - 2 (SC-58635) in Hereditary Non-Polyposis Colorectal Cancer (HNPCC) Patients and Carriers", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Colorectal Neoplasm", "Hereditary Nonpolyposis" ], "interventions": [ { "name": "Celecoxib (SC-58635)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "National Cancer Institute (NCI)", "sponsor_class": "NIH", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": null, "sex": "ALL", "summary": "Not listed" }, "enrollment_count": 20, "start_date": "1998-03", "completion_date": "2002-01", "has_results": false, "last_update_posted_date": "2008-03-04", "last_synced_at": "2026-09-23T19:36:25.167Z", "location_count": 1, "location_summary": "Bethesda, Maryland", "locations": [ { "city": "Bethesda", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT00001693" }, { "nct_id": "NCT03100799", "title": "An Exploratory Clinical Study to Investigate Biomarkers of Senescence in Patients With Osteoarthritis of the Knee", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Osteoarthritis, Knee" ], "interventions": [ { "name": "Arthroscopy", "type": "PROCEDURE" }, { "name": "Arthrocentesis", "type": "PROCEDURE" }, { "name": "MRI", "type": "DIAGNOSTIC_TEST" } ], "intervention_types": [ "PROCEDURE", "DIAGNOSTIC_TEST" ], "sponsor": "Unity Biotechnology, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "35 Years", "maximum_age": null, "sex": "ALL", "summary": "35 Years and older" }, "enrollment_count": 30, "start_date": "2017-03-02", "completion_date": "2017-07-10", "has_results": false, "last_update_posted_date": "2017-08-01", "last_synced_at": "2026-09-23T19:36:25.167Z", "location_count": 1, "location_summary": "Frederick, Maryland", "locations": [ { "city": "Frederick", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT03100799" }, { "nct_id": "NCT00433576", "title": "Resveratrol in Treating Patients With Colorectal Cancer That Can Be Removed By Surgery", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Adenocarcinoma of the Colon", "Adenocarcinoma of the Rectum", "Stage I Colon Cancer", "Stage I Rectal Cancer", "Stage II Colon Cancer", "Stage II Rectal Cancer", "Stage III Colon Cancer", "Stage III Rectal Cancer" ], "interventions": [ { "name": "resveratrol", "type": "DRUG" }, { "name": "pharmacological study", "type": "OTHER" }, { "name": "laboratory biomarker analysis", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "National Cancer Institute (NCI)", "sponsor_class": "NIH", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 20, "start_date": "2006-12", "completion_date": "2009-03", "has_results": false, "last_update_posted_date": "2014-09-15", "last_synced_at": "2026-09-23T19:36:25.167Z", "location_count": 1, "location_summary": "Ann Arbor, Michigan", "locations": [ { "city": "Ann Arbor", "state": "Michigan" } ], "official_url": "https://clinicaltrials.gov/study/NCT00433576" }, { "nct_id": "NCT00217880", "title": "Significance of Biological Markers in Patients With Acute Lung Injury/Acute Respiratory Disease", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Respiratory Distress Syndrome, Adult" ], "interventions": [ { "name": "Bronchoscopy", "type": "PROCEDURE" } ], "intervention_types": [ "PROCEDURE" ], "sponsor": "University of Michigan", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "95 Years", "sex": "ALL", "summary": "18 Years to 95 Years" }, "enrollment_count": 40, "start_date": "2004-07", "completion_date": "2009-06", "has_results": false, "last_update_posted_date": "2013-08-19", "last_synced_at": "2026-09-23T19:36:25.167Z", "location_count": 2, "location_summary": "Atlanta, Georgia • Ann Arbor, Michigan", "locations": [ { "city": "Atlanta", "state": "Georgia" }, { "city": "Ann Arbor", "state": "Michigan" } ], "official_url": "https://clinicaltrials.gov/study/NCT00217880" } ] }